Estimating dementia cases amongst migrants living in Europe.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
09 2019
Historique:
received: 12 11 2018
accepted: 04 04 2019
pubmed: 11 4 2019
medline: 18 8 2020
entrez: 11 4 2019
Statut: ppublish

Résumé

The phenomenon of dementia amongst migrants and ethnic minorities represents an emerging concern for European healthcare systems, posing additional challenges in terms of clinical approach, access to care and resource utilization. The aim of the present study was to estimate the cases of dementia amongst immigrant older subjects living in Europe and in each European country. The estimated cases of dementia amongst older (i.e. 65+) migrants living in the European Union (EU-28) and European Free Trade Association member states were calculated by multiplying the number of migrants (obtained through the data provided by Eurostat) with the age- and sex-specific prevalence rates (derived by a recent meta-analysis). Overall, 6 507 360 older migrants lived in Europe in 2017. In addition, 1 204 671 migrants were registered in Germany in 2010. Nearly 475 000 dementia cases (329 028 women, 147 410 men) were estimated in this population by applying age- and sex-specific prevalence rates. When considering each European country, the number of estimated cases ranged from 108 (Iceland) to 119 161 (France). In parallel, the proportion of dementia cases occurring in migrants ranged from 0.9% (Czech Republic) to 51.2% (Liechtenstein). The issue of dementia in migrants and ethnic minorities is emerging but already relevant for European healthcare systems. The magnitude of this phenomenon and its complexities reinforce the need for coordinated initiatives both at a national and continental level. These epidemiological data should ideally be integrated with those coming from 'real world' services in order to better calibrate these actions.

Sections du résumé

BACKGROUND AND PURPOSE
The phenomenon of dementia amongst migrants and ethnic minorities represents an emerging concern for European healthcare systems, posing additional challenges in terms of clinical approach, access to care and resource utilization. The aim of the present study was to estimate the cases of dementia amongst immigrant older subjects living in Europe and in each European country.
METHODS
The estimated cases of dementia amongst older (i.e. 65+) migrants living in the European Union (EU-28) and European Free Trade Association member states were calculated by multiplying the number of migrants (obtained through the data provided by Eurostat) with the age- and sex-specific prevalence rates (derived by a recent meta-analysis).
RESULTS
Overall, 6 507 360 older migrants lived in Europe in 2017. In addition, 1 204 671 migrants were registered in Germany in 2010. Nearly 475 000 dementia cases (329 028 women, 147 410 men) were estimated in this population by applying age- and sex-specific prevalence rates. When considering each European country, the number of estimated cases ranged from 108 (Iceland) to 119 161 (France). In parallel, the proportion of dementia cases occurring in migrants ranged from 0.9% (Czech Republic) to 51.2% (Liechtenstein).
CONCLUSIONS
The issue of dementia in migrants and ethnic minorities is emerging but already relevant for European healthcare systems. The magnitude of this phenomenon and its complexities reinforce the need for coordinated initiatives both at a national and continental level. These epidemiological data should ideally be integrated with those coming from 'real world' services in order to better calibrate these actions.

Identifiants

pubmed: 30968532
doi: 10.1111/ene.13964
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1191-1199

Informations de copyright

© 2019 EAN.

Auteurs

M Canevelli (M)

Department of Human Neuroscience, 'Sapienza' University, Rome, Italy.
National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.

E Lacorte (E)

National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.

I Cova (I)

Center for Research and Treatment on Cognitive Dysfunctions, 'Luigi Sacco' University Hospital, Milan, Italy.

V Zaccaria (V)

Department of Human Neuroscience, 'Sapienza' University, Rome, Italy.

M Valletta (M)

Department of Human Neuroscience, 'Sapienza' University, Rome, Italy.

R Raganato (R)

Department of Human Neuroscience, 'Sapienza' University, Rome, Italy.

G Bruno (G)

Department of Human Neuroscience, 'Sapienza' University, Rome, Italy.

A M Bargagli (AM)

Department of Epidemiology, Regional Health Service, Rome, Italy.

S Pomati (S)

Center for Research and Treatment on Cognitive Dysfunctions, 'Luigi Sacco' University Hospital, Milan, Italy.

L Pantoni (L)

Department of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan, Milan, Italy.

N Vanacore (N)

National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH